1. Overview of Pharmacokinetics and Liver Toxicities of Radix Polygoni Multiflori
   Dan Li et al, 2020, Toxins CrossRef
2. Idiosyncratic liver injury induced by bolus combination treatment with emodin and 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucopyranoside in rats
   Dan Li et al, 2022, Frontiers in Pharmacology CrossRef
3. Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability Assay
   Claudia Cipriani et al, 2022, Pharmaceuticals CrossRef
4. Medicinal plants cultivated in Egypt with anticancer potential; a systematic review
   Iman Abdelhady Elshnoudy et al, 2024, Phytochemistry Reviews CrossRef
5. Therapeutic Potential of Emodin for Gastrointestinal Cancers
   Sierra J. McDonald et al, 2022, Integrative Cancer Therapies CrossRef
6. Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis
   Chung-Chun Wu et al, 2019, Cancers CrossRef
7. Emodin Sensitizes Cervical Cancer Cells to Vinblastine by Inducing Apoptosis and Mitotic Death
   Wojciech Trybus et al, 2022, International Journal of Molecular Sciences CrossRef
8. Potential Hepatotoxins Found in Herbal Medicinal Products: A Systematic Review
   Nguyen Van Quan et al, 2020, International Journal of Molecular Sciences CrossRef
9. Long non‑coding RNA RP11‑81H3.2 suppresses apoptosis by targeting microRNA‑1539/COL2A1 in human nucleus pulposus cells
   Lin Qiao et al, 2021, Experimental and Therapeutic Medicine CrossRef
10. Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin
    Esra Küpeli Akkol et al, 2021, Cancers CrossRef
11. Isoliquiritigenin attenuates emodin-induced hepatotoxicity in vivo and in vitro through Nrf2 pathway
    Boran Ni et al, 2022, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology CrossRef
12. Emodin is a Potential Drug Targeting CD44-positive Hepatocellular Cancer
    Yuan Gao et al, 2024, Current Cancer Drug Targets CrossRef